Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 897 results for "glenmark"

Glenmark Enters Oncology With the Discovery and Initiation of IND Enabling Studies of an Innovative Bispecific Antibody
PR Newswire

Glenmark discovers new molecule; enters oncology segment

to treat various types of cancers. Glenmark Pharmaceuticals SA, a wholly-owned unit of Glenmark, announces the discovery and initiation of studies of a novel clinical development candidate, GBR 1302, the company said in a statement. GBR 1302, which was ... Business Standard, 10 hours ago
Pharma Letter

Glenmark study on novel antibody

Drugmaker Glenmark Pharmaceuticals is set to initiate studies on its novel drug candidate, GBR 1302, an antibody with dual specificities. Explaining the significance of the discovery, Michael Buschle, Glenmark's Chief Scientific Officer and ...
 Hindu Business Line5 hours ago Glenmark reports strong growth everywhere but the USA  Pharma Letter3 weeks ago Glenmark's consolidated revenue increases by 20.08 % to Rs. 14,869.40 Mn for Q1 - FY 14 15  FirstWord Pharma3 weeks ago Glenmark Advances Antibody Into Phase I In Autoimmune Diseases  Bioresearch Online1 month ago

Glenmark develops new anti-cancer drug

Glenmark expects to obtain approval for the initiation of clinical studies for the drug during this fiscal year. Mumbai: Glenmark Pharmaceuticals Ltd , which is focusing on inventing new medicines as one of its core areas of business, has entered ...
 Livemint.com16 hours ago Glenmark Generics receives ANDA approval  Express Pharma4 weeks ago Glenmark receives ANDA nod for Telmisartan  Bio Spectrum Asia1 month ago Glenmark gets USFDA approval for skin infection cream  VC Circle1 month ago

Glenmark launches new cancer drug molecule

Mumbai-based Glenmark Pharmaceuticals Ltd, innovator of new drug molecules, has entered into cancer treatment space with its latest discovery of a new drug molecule. Glenmark Pharmaceuticals SA, its Switzerland-based research unit, has initiated studies of a ...
 Business Standard9 hours ago

Glenmark Pharma moves higher on new molecule for cancer

The stock of drug maker Glenmark Pharma hit a new high of ₹749 on Wednesday after the company announced the discovery of a new biological molecule targeting cancer. The molecule named GBR 1302 is based on Glenmark's proprietary antibody technology ...
 Hindu Business Line14 hours ago

Glenmark Pharma hits record high

IST on BSE after the firm said its wholly owned subsidiary announced the discovery and initiation of IND enabling studies of a novel clinical development candidate, GBR 1302. The announcement was made before market hours today, 20 August 2014. Meanwhile, the ...
 Business Standard17 hours ago

Go long in Glenmark, Hindzinc and Titan: SMC Global

After a long weekend, the domestic markets started the week on higher note and got succeed to hit record high. The benchmark nifty ended near to 7900 levels on the back of buying across the sectors such as bank, capital goods, power and Oil & Gas ...
 Smart Investor1 day ago

Buy Glenmark with a target of Rs 725: Ashwani Gujral

Follow this section for latest news on Views/Recommendations EmailRSS Have something to say? Post your comment Comments are moderated and will be allowed if they are about the topic and not abusive. Characters remaining ( 1500 ) To post this comment you must ...
 Economic Times1 week ago Buy Glenmark Pharma with a target of Rs 720: Prakash Gaba  Economic Times1 week ago Motilal Oswal neutral on Glenmark Pharma; target Rs 654  Money Control2 weeks ago Buy Glenmark Pharma; target of Rs 728: Emkay  Money Control2 weeks ago

Glenmark Pharma may test Rs 740: Chandan Taparia

Chandan Taparia, Derivative Technical Analyst at Anand Rathi Securities is of the view that Glenmark Pharma may test Rs 740.
 Money Control1 week ago Glenmark Pharma may test Rs 645: SP Tulsian  Money Control1 month ago

Buy Dabur, Glenmark Pharma, HCL Tech: Sudarshan Sukhani

Sudarshan Sukhani of recommends buying Dabur India, Glenmark Pharma and HCL Technologies.
 Money Control1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less